Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Implant System in Knee Osteoarthritis
NCT02873273Phase 1Completed
- Start
- Oct 2016
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dexamethasone in osteoarthritis (OA). Primary endpoints: Incidence of treatment emergent adverse events at 24 weeks and Change from baseline in weekly mean of the pain intensity score at 24 weeks. Started Oct 2016; status: completed.
02
Drugs
dexamethasone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02873273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02873273.